Covid-19 Boosters — Where from Here?
Latest on Omicron Variant and COVID-19 Vaccine Protection
Genetic changes raise the possibility that Omicron could cause breakthrough infections in people who’ve already received a Pfizer or Moderna mRNA vaccine. Read More
Questions About Herd Immunity and Vaccination?
As flu season begins and communities wait for a COVID-19 vaccine, Nursing at Georgetown created this resource to help people learn more about herd immunity by addressing misconceptions and encouraging conversations about the importance of vaccination. Access answers here.
Could COVID Pandemic and Vaccine Hesitancy Let HPV, Polio, and Measles Return?
Vaccine skepticism could allow previously well-managed viruses and diseases to start reappearing. Read More
Should I be concerned about the Delta Variant?
New data show Delta is different than past versions: It is much more contagious.
- Vaccinated people can get breakthrough infections of Delta variant and may be contagious
- Vaccinated individuals represent a very small amount of total transmission.
Check updates on the Delta variant here.
COVID-19 Frequently Asked Questions
- Is the Coronavirus vaccine Safe?
- Will Coronavirus Vaccines Have Long-Term Side Effects?
- COVID Vaccine Arrive at BU: Everything You Need to Know
- Virus Mutation: Why and How Virus Mutate?
- Covid Vaccine Facts: Find answers to your questions about COVID-19 vaccines.
- Does Vaccination Mean the End of Masking and Social Distancing?
- How a New Vaccine is Developed, Approved, and Manufactured?
- What Should I Know About COVID-19 Vaccines For Elderly Adults?
- COVID Vaccine Graphics: Why Get It, and What Happens Next?
- What About Allergic Reaction to COVID-19 Vaccine?
- What About COVID-19 Vaccinations for Individuals With Certain Medical Conditions?
- Any Research underway to Prevent, Detect, and Treat COVID-19 and its Effects on our Health?
- Are COVID-19 mRNA Vaccines Safe, Effective for Pregnant Women?
COVID-19 Vaccination* Communication
Although newly developed COVID-19 vaccines are poised to be a powerful tool in the control of the devastating COVID-19 pandemic, the public’s confidence in and willingness to receive the vaccines will determine the outcome of this mass-scale public health intervention. This report, which was developed in consultation with leading, experts in social and behavioral sciences and public health outlines evidence-informed communication strategies in support of national COVID-19 vaccine distribution efforts across federal agencies and their state and local partners.
COVID-19 Vaccine Development: Behind the Scenes
Years of research enable a COVID-19 vaccine to be developed in record time.
Developing a vaccine and bringing it to market often takes many years. But because of work that NIH was already doing when the COVID-19 pandemic began, researchers were able to come up with vaccines for this new virus much faster.
Trustworthiness before Trust – Covid-19 Vaccine Trials and the Black Community
As the race to develop a vaccine for Covid-19 has reached phase 3 clinical trials, concerns are increasing about the low rates of trial participation in important subgroups, including Black communities. Recent data show that although Black people make up 13% of the U.S. population, they account for 21% of deaths from Covid-19 but only 3% of enrollees in vaccine trials.
COVID-19 Vaccine Education Initiative Toolkits
As part of the large-scale COVID-19 Vaccine Education Initiative, the Ad Council and the COVID Collaborative have released a public health toolkit to help organizations create educational content that will help build confidence in the COVID-19 vaccines. Explore the toolkit for public service announcements, FAQs, language dos and don’ts, and key audience insights for the public health sector.
More for the Community
- How Can You Participate?: COVID-19 Research Trials
- Should I Join? “COVID-19 Clinical Research Flyers”
I am Healthy: Should I Join a COVID-19 Research Study?
I am a Healthy Child: Should I Join a COVID-19 Research Study?
I am Sick with COVID-19: Should I Join a COVID-19 Research Study?
My Child has COVID-19: Should they Join a COVID-19 Research Study?
I am a Child with COVID-19: Should I Join a COVID-19 Research Study?
Vaccine Research: Should I Join a COVID-19 Vaccine Research Study?
Giving Samples for COVID-19 Research
COVID-19 Vaccine News Highlights
- Moderna COVID-19 vaccine generates long-lasting immune memory
- Vaccines prevented up to 140,000 COVID-19 deaths in the U.S.
- BU Clinical Testing Lab passes milestone of one million COVID tests, and 7,000 BU community members are now fully vaccinated
- Immune response to vaccination after COVID-19
- Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
- COVID-19 Vaccine Two-Dose Completion Is Crucial for Public Health
- Efficacy of Current Covid-19 Vaccines against Variant Viruses
- BMC Launches COVID-19 Vaccination Program for Homebound Seniors
- Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
- What I’ve Learned as a Pediatrician About Vaccine Hesitancy
- Escaping Catch-22 — Overcoming Covid Vaccine Hesitancy
- There’s A Long Road Ahead, But Local Infectious Disease Experts Are Hopeful for 2021
- Help Address Vaccine Hesitancy and Uptake Among Populations Experiencing Health Disparities
- For Physicians & Nurses: Answers to COVID-19 Vaccination Questions for HCPs | Ad Council
Covid-19 Vaccine Webinars
In this webinar, Dr. Anne Schuchat, principal deputy director of the CDC, and Charysse Nunez, insights lead for the Ad Council’s COVID Campaign, provided updates on the COVID-19 pandemic, vaccinations, and communications efforts.